Tue, Sep 16, 2014, 12:08 PM EDT - U.S. Markets close in 3 hrs 52 mins

Recent

% | $
Quotes you view appear here for quick access.

Neurocrine Biosciences Inc. Message Board

you are viewing a single comment's thread.

view the rest of the posts
  • nowwheretogo22004 nowwheretogo22004 Jan 9, 2013 9:26 AM Flag

    JP Morgan Conference

    They do plenty of investor conferences. They really didn't need it. We seem to have survived that Seeking Alpha article. Although they went into vivid detail on everything that could go wrong, they did also think that getting approval of the drug was very, very high. We really need some news on someone stepping in and doing a new Lupron drug, since the patents are expiring. Something needs to force Abbv's hand into going strong with Elagolix.

    SortNewest  |  Oldest  |  Most Replied Expand all replies
    • Indeed that Seeking article is actually really good news for NBIX. Altho it did point out all the negatives one positive point is greater than all the negatives combined. It did point out to excellent chance of getting approved. That alone my friends will put NBIX at $16. GLTA.

 
NBIX
15.47-0.10(-0.64%)12:08 PMEDT

Trending Tickers

i
Trending Tickers features significant U.S. stocks showing the most dramatic increase in user interest in Yahoo Finance in the previous hour over historic norms. The list is limited to those equities which trade at least 100,000 shares on an average day and have a market cap of more than $300 million.